Clinical Trial Update: Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting long-term efficacy and safety of aflibercept intravitreal injections for clinically significant diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• aflibercept intravitreal injections (aflibercept)

Snippet

Sponsor: Retina-Vitreous Associates Medical Group | Conditions: Clinically Significant Diabetic Macular Edema | Phase 4 | Status: COMPLETED